Product
JX11502MA
1 clinical trial
1 indication
Indication
SchizophreniaClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of JX11502MA Capsules in Patients With Schizophrenia.Status: Completed, Estimated PCD: 2022-12-27